Tonix Pharmaceuticals Holding (TNXP) Operating Margin (2022 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted Operating Margin of 314.05% for Q2 2026, up 48.0% on a QoQ basis from 603.91% in Q1 2026, and up 110217.0% year-over-year from N/an in Q2 2025.
Powered by 
Analysis
Tonix Pharmaceuticals Holding (TNXP) Operating Margin (2022 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding has reported Operating Margin for 5 years, with the latest figure at 314.05% in Q2 2026.
- On a quarterly basis, Operating Margin rose 110217.0% year-over-year to 314.05% in Q2 2026; TTM through Jun 2026 was 568.43%, a 26957.0% increase from a year earlier, with the FY2025 full-year figure at 959.05%, up 39523.0% from the prior year.
- Operating Margin was 314.05% for Q2 2026 at Tonix Pharmaceuticals Holding, up from 603.91% in the prior quarter.
- The five-year high for Operating Margin was 314.05% in Q2 2026, with the low at 3501.63% in Q2 2024.
- Average Operating Margin over 5 years is 948.92%, with a median of 814.06% recorded in 2022.
- The sharpest annual moves came in 2024 and 2025: Operating Margin slumped 268329 bps in 2024, then jumped 208541 bps in 2025.
- Over 5 years, Operating Margin stood at 814.06% in 2022, then rose by 11 bps to 723.18% in 2023, then slipped by 20 bps to 870.64% in 2024, then dropped by 3 bps to 895.84% in 2025, then jumped by 65 bps to 314.05% in 2026.
- The last three Operating Margin figures came in at 314.05% (Q2 2026), 603.91% (Q1 2026), and 895.84% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 32.97% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 28.37% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 9.03% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 19.06% |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 41.69% |
| 10 | Tonix Pharmaceuticals Holding | 220.65 Mn | 220.65 Mn | 12.84 Mn | -314.05% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -314.05% |
| Mar 31, 2026 | -603.91% |
| Dec 31, 2025 | -895.84% |
| Sep 30, 2025 | -1,005.08% |
| Jun 30, 2025 | -1,416.22% |
| Mar 31, 2025 | -660.93% |
| Dec 31, 2024 | -870.64% |
| Sep 30, 2024 | -551.17% |
| Jun 30, 2024 | -3,501.63% |
| Mar 31, 2024 | -860.23% |
| Dec 31, 2023 | -723.18% |
| Sep 30, 2023 | -705.62% |
| Jun 30, 2023 | -818.34% |
| Sep 30, 2022 | -814.06% |
| Jun 30, 2022 | -492.84% |